Category: Review

Research progress of intervention treatment on the retinal ischemia-reperfusion injury

2017, No. 05, Review

Authors: Zhang Xue,  Sun Dawei DOI: 10.3760/cma.j.issn.2095-0160.2017.05.016 Published 2017-05-10 Cite as Chin J Exp Ophthalmol, 2017,35(5): 463-467. Abstract                              [Download PDF] [Read Full Text] Retinal ischemia-reperfusion injury (RIRI) is a common pathological and physiological clinical oculopathy, which can occur in retinal artery and vein occlusion, diabetic retinopathy and […]

Advances in genetic study of primary open angle glaucoma

2017, No. 06, Review

Authors: Yao Yihua,  Zhu Yihua,  Yang Juhua DOI: 10.3760/cma.j.issn.2095-0160.2017.06.018 Published 2017-06-10 Cite as Chin J Exp Ophthalmol, 2017,35(06): 572-576. Abstract                               [Download PDF] [Read Full Text] Primary open angle glaucoma (POAG) is a complex and heterogeneous neurodegenerative disease caused by genetic and environmental factors, and […]

Surgical options for the correction of presbyopia

2017, No. 06, Review

Authors: Liu Ting,  Bai Ji,  Yu Ting DOI: 10.3760/cma.j.issn.2095-0160.2017.06.017 Published 2017-06-10 Cite as Chin J Exp Ophthalmol, 2017,35(06): 567-571. Abstract                              [Download PDF] [Read Full Text] Presbyopia is an age-related eye condition, and its most prominent sign is the reduction in the amplitude of accommodation, resulting in the disability […]

Treatment of amblyopia emerging from plasticity of the visual cortex and binocular vision

2017, No. 06, Review

Authors: Ao Mingxin,  Bu Juan DOI: 10.3760/cma.j.issn.2095-0160.2017.06.016 Published 2017-06-10 Cite as Chin J Exp Ophthalmol, 2017,35(06): 561-566. Abstract                               [Download PDF] [Read Full Text] Amblyopia is a developmental visual disorder, which is accompanied by physiological changes in the visual cortex.Many studies that focused on the treatments of amblyopia […]

Advances of muscarinic antagonists slowing the progression of myopia

2017, No. 06, Review

Authors: Chen Hui,  Jiang Qin DOI: 10.3760/cma.j.issn.2095-0160.2017.06.015 Published 2017-06-10 Cite as Chin J Exp Ophthalmol, 2017,35(06): 556-560. Abstract                              [Download PDF] [Read Full Text] The myopic population is growing rapidly worldwide, the treatment of myopia become one of the hot spots in ophthalmology.Medicine therapy of myopia is now […]

Risk factors for corneal endothelium dysfunction

2017, No. 07, Review

Authors: Wang Shuangning,  Li Xia DOI: 10.3760/cma.j.issn.2095-0160.2017.07.020 Published 2017-07-10 Cite as Chin J Exp Ophthalmol, 2017,35(07): 669-672. Abstract                              [Download PDF] [Read Full Text] Density of corneal endothelium is commonly used by clinician to evaluate the function of corneal endothelium.The importance of dysfunction of […]

Research progress of diabetic macular edema and its risk factors

2017, No. 07, Review

Authors: Li Wei,  Wu Qiang DOI: 10.3760/cma.j.issn.2095-0160.2017.07.019 Published 2017-07-10 Cite as Chin J Exp Ophthalmol, 2017,35(07): 664-668. Abstract                               [Download PDF] [Read Full Text] Diabetic macular edema (DME) is a common complication of diabetes that can lead to severely impaired visual acuity.Its pathogenesis is complex, which is closely […]

Research progress of diabetic retinopathy with dyslipidemia

2017, No. 07, Review

Authors: Zhao Mengya,  Xu Xun DOI: 10.3760/cma.j.issn.2095-0160.2017.07.017 Published 2017-07-10 Cite as Chin J Exp Ophthalmol, 2017,35(07): 655-659. Abstract                              [Download PDF] [Read Full Text] Diabetic retinopathy (DR) is one of the major microvascular complications of diabetes, it is the most common cause of preventable blindness in diabetic adults […]